Table 4.

Sites and overall 5-year survival rates in patients with gastroenteropancreatic NETs in the USA (from the SEER Programme), Norway (from the NRC) and England and Wales^{12–14 37}

Site	Percentage surviving
	SEER data (n=17 312)			England and Wales
	Black patients	White patients	NRC data (n=2013)	Well-differentiated tumours	Small cell tumours*
Lung	36	48	54	–	–
Stomach	56	64	45	52	18
Small intestine	64	70	59	59	27
Pancreas	27	35	43	39	17
Appendix	70	79	74	–	–
Colon	61	53	41	65	27
Rectum	85	88	74	–	–

^*Data are for 1-year survival.

NET, neuroendocrine tumour; NRC, Norwegian Registry of Cancer; SEER, Surveillance, Epidemiology and End Results.